|
Post by rfogel on Apr 14, 2020 7:53:26 GMT -5
I stumbled across this: www.ncbi.nlm.nih.gov/pmc/articles/PMC5863311/"Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice" It gives very detailed instructions on initiating therapy, determining the starting dose, converting from RAA dose to afrezza dose, etc. It looks pretty useful. Could Mannkind include that info on the website? Or at least a link to the paper?
|
|
|
Post by slugworth008 on Apr 14, 2020 9:29:46 GMT -5
Discuss. afrezza.com/I like it. Job well done. Much more user friendly, conveys many points much better, shows the uniqueness of Afrezza much better. Better website flow and easier to understand. I like the colorway. A+ It's about damn time - years overdue. But I'll take it.
|
|
bac
Lab Rat
Posts: 37
|
Post by bac on Apr 14, 2020 12:28:19 GMT -5
Funded by MannKind and published March 2018.
|
|
|
Post by prcgorman2 on Apr 14, 2020 12:38:37 GMT -5
Communications via "digital transformation" have taken on greater emphasis during the COVID shut-down, and web development is one of the business and marketing areas still able to progress usefully. My daughter (who used to work in marketing for a small pharma) suddenly had her web-development budget improved because other areas of more hands-on marketing are sidelined and her company's website needed a face lift.
|
|